Oleic acid activates peroxisome proliferator-activated receptor δ to compensate insulin resistance in steatotic cells

Hung Tsung Wu, Wency Chen, Kai Chun Cheng, Po Ming Ku, Ching Hua Yeh, Juei Tang Cheng

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Nonalcoholic fatty liver disease is frequently associated with type 2 diabetes; however, this idea is challenged by recent studies because hepatic steatosis is not always associated with insulin resistance (IR). Oleic acid (OA) is known to induce hepatic steatosis with normal insulin sensitivity; however, the mechanism is still unknown. Previous studies depict that activation of peroxisome proliferator-activated receptor δ (PPARδ[U+F029]) improves hepatic steatosis and IR, whereas the role of PPARδ in the improvement of insulin sensitivity by OA is unknown. Here we induced steatosis in HepG2 cells by incubation with OA and OA significantly increased the expression of PPARδ through a calcium-dependent pathway. OA also induced the expression of G protein-coupled receptor 40 (GPR40), and deletion of GPR40 by small interfering ribonucleic acid transfection partially reversed the effect of OA on PPARδ[U+F02E]. Inhibition of phospholipase C (PLC) by U73122 also reversed OA-induced PPARδ expression. Otherwise, deletion of PPARδ augmented the OA-induced steatosis in HepG2 cells. Furthermore, IR was developed in OA-treated HepG2 cells with PPARδ deletion, while insulin-related signals and insulin-stimulated glycogen synthesis were reduced through increase of phosphatase and tensin homolog (PTEN) expression. In conclusion, OA activates GPR40-PLC-calcium pathway to increase the expression of PPARδ and PPARδ further decreased the expression of PTEN to regulate insulin sensitivity in hepatic steatosis.

Original languageEnglish
Pages (from-to)1264-1270
Number of pages7
JournalJournal of Nutritional Biochemistry
Volume23
Issue number10
DOIs
Publication statusPublished - Oct 1 2012
Externally publishedYes

Fingerprint

Peroxisome Proliferator-Activated Receptors
Oleic Acid
Insulin Resistance
Insulin
Hep G2 Cells
G-Protein-Coupled Receptors
Liver
Type C Phospholipases
Phosphoric Monoester Hydrolases
Calcium
Medical problems
Glycogen
Type 2 Diabetes Mellitus
Transfection
Chemical activation
RNA

Keywords

  • Hepatic steatosis
  • Insulin resistance
  • Oleic acid
  • Peroxisome proliferator-activated receptor δ
  • PTEN

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Molecular Biology
  • Nutrition and Dietetics
  • Clinical Biochemistry

Cite this

Oleic acid activates peroxisome proliferator-activated receptor δ to compensate insulin resistance in steatotic cells. / Wu, Hung Tsung; Chen, Wency; Cheng, Kai Chun; Ku, Po Ming; Yeh, Ching Hua; Cheng, Juei Tang.

In: Journal of Nutritional Biochemistry, Vol. 23, No. 10, 01.10.2012, p. 1264-1270.

Research output: Contribution to journalArticle

Wu, Hung Tsung ; Chen, Wency ; Cheng, Kai Chun ; Ku, Po Ming ; Yeh, Ching Hua ; Cheng, Juei Tang. / Oleic acid activates peroxisome proliferator-activated receptor δ to compensate insulin resistance in steatotic cells. In: Journal of Nutritional Biochemistry. 2012 ; Vol. 23, No. 10. pp. 1264-1270.
@article{cb6872dc0a2749ddacdbfcfc2b85cf88,
title = "Oleic acid activates peroxisome proliferator-activated receptor δ to compensate insulin resistance in steatotic cells",
abstract = "Nonalcoholic fatty liver disease is frequently associated with type 2 diabetes; however, this idea is challenged by recent studies because hepatic steatosis is not always associated with insulin resistance (IR). Oleic acid (OA) is known to induce hepatic steatosis with normal insulin sensitivity; however, the mechanism is still unknown. Previous studies depict that activation of peroxisome proliferator-activated receptor δ (PPARδ[U+F029]) improves hepatic steatosis and IR, whereas the role of PPARδ in the improvement of insulin sensitivity by OA is unknown. Here we induced steatosis in HepG2 cells by incubation with OA and OA significantly increased the expression of PPARδ through a calcium-dependent pathway. OA also induced the expression of G protein-coupled receptor 40 (GPR40), and deletion of GPR40 by small interfering ribonucleic acid transfection partially reversed the effect of OA on PPARδ[U+F02E]. Inhibition of phospholipase C (PLC) by U73122 also reversed OA-induced PPARδ expression. Otherwise, deletion of PPARδ augmented the OA-induced steatosis in HepG2 cells. Furthermore, IR was developed in OA-treated HepG2 cells with PPARδ deletion, while insulin-related signals and insulin-stimulated glycogen synthesis were reduced through increase of phosphatase and tensin homolog (PTEN) expression. In conclusion, OA activates GPR40-PLC-calcium pathway to increase the expression of PPARδ and PPARδ further decreased the expression of PTEN to regulate insulin sensitivity in hepatic steatosis.",
keywords = "Hepatic steatosis, Insulin resistance, Oleic acid, Peroxisome proliferator-activated receptor δ, PTEN",
author = "Wu, {Hung Tsung} and Wency Chen and Cheng, {Kai Chun} and Ku, {Po Ming} and Yeh, {Ching Hua} and Cheng, {Juei Tang}",
year = "2012",
month = "10",
day = "1",
doi = "10.1016/j.jnutbio.2011.07.006",
language = "English",
volume = "23",
pages = "1264--1270",
journal = "Journal of Nutritional Biochemistry",
issn = "0955-2863",
publisher = "Elsevier Inc.",
number = "10",

}

TY - JOUR

T1 - Oleic acid activates peroxisome proliferator-activated receptor δ to compensate insulin resistance in steatotic cells

AU - Wu, Hung Tsung

AU - Chen, Wency

AU - Cheng, Kai Chun

AU - Ku, Po Ming

AU - Yeh, Ching Hua

AU - Cheng, Juei Tang

PY - 2012/10/1

Y1 - 2012/10/1

N2 - Nonalcoholic fatty liver disease is frequently associated with type 2 diabetes; however, this idea is challenged by recent studies because hepatic steatosis is not always associated with insulin resistance (IR). Oleic acid (OA) is known to induce hepatic steatosis with normal insulin sensitivity; however, the mechanism is still unknown. Previous studies depict that activation of peroxisome proliferator-activated receptor δ (PPARδ[U+F029]) improves hepatic steatosis and IR, whereas the role of PPARδ in the improvement of insulin sensitivity by OA is unknown. Here we induced steatosis in HepG2 cells by incubation with OA and OA significantly increased the expression of PPARδ through a calcium-dependent pathway. OA also induced the expression of G protein-coupled receptor 40 (GPR40), and deletion of GPR40 by small interfering ribonucleic acid transfection partially reversed the effect of OA on PPARδ[U+F02E]. Inhibition of phospholipase C (PLC) by U73122 also reversed OA-induced PPARδ expression. Otherwise, deletion of PPARδ augmented the OA-induced steatosis in HepG2 cells. Furthermore, IR was developed in OA-treated HepG2 cells with PPARδ deletion, while insulin-related signals and insulin-stimulated glycogen synthesis were reduced through increase of phosphatase and tensin homolog (PTEN) expression. In conclusion, OA activates GPR40-PLC-calcium pathway to increase the expression of PPARδ and PPARδ further decreased the expression of PTEN to regulate insulin sensitivity in hepatic steatosis.

AB - Nonalcoholic fatty liver disease is frequently associated with type 2 diabetes; however, this idea is challenged by recent studies because hepatic steatosis is not always associated with insulin resistance (IR). Oleic acid (OA) is known to induce hepatic steatosis with normal insulin sensitivity; however, the mechanism is still unknown. Previous studies depict that activation of peroxisome proliferator-activated receptor δ (PPARδ[U+F029]) improves hepatic steatosis and IR, whereas the role of PPARδ in the improvement of insulin sensitivity by OA is unknown. Here we induced steatosis in HepG2 cells by incubation with OA and OA significantly increased the expression of PPARδ through a calcium-dependent pathway. OA also induced the expression of G protein-coupled receptor 40 (GPR40), and deletion of GPR40 by small interfering ribonucleic acid transfection partially reversed the effect of OA on PPARδ[U+F02E]. Inhibition of phospholipase C (PLC) by U73122 also reversed OA-induced PPARδ expression. Otherwise, deletion of PPARδ augmented the OA-induced steatosis in HepG2 cells. Furthermore, IR was developed in OA-treated HepG2 cells with PPARδ deletion, while insulin-related signals and insulin-stimulated glycogen synthesis were reduced through increase of phosphatase and tensin homolog (PTEN) expression. In conclusion, OA activates GPR40-PLC-calcium pathway to increase the expression of PPARδ and PPARδ further decreased the expression of PTEN to regulate insulin sensitivity in hepatic steatosis.

KW - Hepatic steatosis

KW - Insulin resistance

KW - Oleic acid

KW - Peroxisome proliferator-activated receptor δ

KW - PTEN

UR - http://www.scopus.com/inward/record.url?scp=84866316797&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866316797&partnerID=8YFLogxK

U2 - 10.1016/j.jnutbio.2011.07.006

DO - 10.1016/j.jnutbio.2011.07.006

M3 - Article

C2 - 22209682

AN - SCOPUS:84866316797

VL - 23

SP - 1264

EP - 1270

JO - Journal of Nutritional Biochemistry

JF - Journal of Nutritional Biochemistry

SN - 0955-2863

IS - 10

ER -